SpaceExpander: Automated Drafting and Evaluation of Markush Claims for Chemical Space Expansion

preprint OA: closed
Full text JSON View at publisher

Abstract

Drafting Markush claims for chemical patents remains difficult because manual claim writing is slow, error prone, and often fails to capture related chemical space in a systematic manner. We developed SpaceExpander, a computational method that converts disclosed compounds into generalized Markush claims by extracting core scaffolds, defining variable positions, decomposing complex substituents, and expanding substituent space through fragment matching. We evaluated the method on 24 publicly available chemical patents and compared its performance with IntelliPatent. SpaceExpander achieved a mean atom level scaffold accuracy of 0.92 and exactly recovered the reference scaffold in 19 of 24 patents. By contrast, IntelliPatent could process only 2 patents from the same set, indicating more limited applicability to structurally diverse cases. We further examined practical claim coverage in a case study based on the Osimertinib patent. Using representative disclosed compounds as input, SpaceExpander drafted a Markush claim that covered 5 of 7 additional approved third-generation EGFR inhibitors beyond Osimertinib. These results show that SpaceExpander is a validated method for automated Markush claim drafting and chemical space expansion.
Full text 1,338 characters · extracted from oa-doi-fallback · click to expand
Abstract Drafting Markush claims for chemical patents remains difficult because manual claim writing is slow, error prone, and often fails to capture related chemical space in a systematic manner. We developed SpaceExpander, a computational method that converts disclosed compounds into generalized Markush claims by extracting core scaffolds, defining variable positions, decomposing complex substituents, and expanding substituent space through fragment matching. We evaluated the method on 24 publicly available chemical patents and compared its performance with IntelliPatent. SpaceExpander achieved a mean atom level scaffold accuracy of 0.92 and exactly recovered the reference scaffold in 19 of 24 patents. By contrast, IntelliPatent could process only 2 patents from the same set, indicating more limited applicability to structurally diverse cases. We further examined practical claim coverage in a case study based on the Osimertinib patent. Using representative disclosed compounds as input, SpaceExpander drafted a Markush claim that covered 5 of 7 additional approved third-generation EGFR inhibitors beyond Osimertinib. These results show that SpaceExpander is a validated method for automated Markush claim drafting and chemical space expansion. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00